Numerous genetic variants associated with risk for schizophrenia have been identified. However, little is known about how these genes have their effects in the… » »   

A scientific review paper warns that people need to find ways to reduce chronic stress and anxiety in their lives or they may be… » »   

In the first study of its kind, researchers have shown that inadequate maternal iron intake during pregnancy exerts subtle effects on infant brain development.… » »   

Activating receptors in the brain for the body’s hunger hormone increases food-related behaviors, such as gathering, storing and consuming food, a finding that has… » »   

A gene linked in previous research, appears to predict more severe post-traumatic stress disorder (PTSD) symptoms as well as a thinner cortex in regions… » »   

A considerable gap exists in mental health and substance abuse treatments known as psychosocial interventions between what is known to be effective and those… » »   

More than 80 percent of people with depression in the general population aren’t eligible for clinical trials of antidepressant drugs, according to a study… » »   

The U.S. Food and Drug Administration approved Danish drugmaker H. Lundbeck A/S and Japan’s Otsuka Pharmaceutical Co Ltd’s Rexulti, an anti-psychotic drug used to… » »   

The selective serotonin reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist vilazodone (Viibryd, Forest Laboratories, Inc), currently approved for the treatment of major depressive… » »   

Elevated activation of the kynurenine pathway (KP) may be an objective signal of suicidality in adolescents with major depressive disorder (MDD), new research indicates.